Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 149

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 19
Chunk 149
---
643        —               ( 524,643      50,542           ( 474,101  
  Foreign currency translation adjustment                        —              —                —                26,163             26,163      6,366               32,529  
  Reverse capitalization                                         —              ( 6,028,690      —                —             ( 6,028,690      —              ( 6,028,690  
  Settlement of subscription receivable                          127,564        —                —                —                 127,564      —                  127,564  
  Remeasurement of share based compensation                      —              ( 2,766,856      —                —             ( 2,766,856      —              ( 2,766,856  
  Issuance of shares under ELOC/Note Conversion arrangement      ( 204,000      4,586,236        —                —               4,382,236      —                4,382,236  
  Balance, December 31, 2024                                     ( 204,000      122,505          ( 985,994        18,875        ( 1,048,614      ( 433,143      ( 1,481,757  

  The no of shares as presented have been adjusted retrospectively for a Reverse Share Split effected in February 2025 of 1 share for every 20 existing share issued.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Re-presented as mentioned in Note 23                                                                                                                                 

The accompanying notes are an integral part of
these consolidated financial statements.

F-6

NEWGENIVF GROUP
LIMITED

                                                                                                December 31,                                                                 
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                                                                2024                               2023**                                    
  CASH FLOWS FROM OPERATING ACTIVITIES                                                                                                                                       
  Net (loss) income                                                                             $                   ( 474,101      $               108,418          135,847  
  Adjustments to reconcile net (loss) income to net cash provided by operating activities:                                                                                   
  Depreciation of plant and equipment                                                                                  19,502                       31,173          100,533  
  Amortization of right-of-use assets                                                                                 186,762                      198,535